BioAtla Insider Trades

BCAB

Track insider trading activity from BioAtla executives and directors. See which insiders are buying and selling BCAB stock.

Trades Last 12 Months

BCAB Price

All Insider Trades for BioAtla

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Short Jay M Phd Chief Executive Officer
Holding Value $9.04M 2,659,603 shares
Last Trade
Mar 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.64M 430,000 shares
$8.47
$3.40
Vasquez Christian Chief Financial Officer
Holding Value $1.8M 530,196 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 240,000 shares
$8.61
$3.40
Sievers Eric Chief Medical Officer
Holding Value $2.04M 598,705 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 240,000 shares
$8.61
$3.40
Waldron Richard A Former Chief Financial Officer
Holding Value $1.17M 343,421 shares
Last Trade
Feb 28, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.8k 2,729 shares
$12.37
$3.40
Williams Eddie Director
Holding Value $205k 60,200 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36k 23,500 shares
$0.40
$3.40
Gray Mary Ann Director
Holding Value $263k 77,397 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36k 23,500 shares
$0.40
$3.40
Mcbrinn Sylvia Director
Holding Value $201k 59,125 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36k 23,500 shares
$0.40
$3.40
Moran Susan Director
Holding Value $178k 52,307 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36k 23,500 shares
$0.40
$3.40
Holding Value $1.09M 321,550 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36k 23,500 shares
$0.40
$3.40
Holding Value $267k 78,459 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36k 23,500 shares
$0.40
$3.40
Holding Value $170 50 shares
Last Trade
Jun 14, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$347M 8,682,254 shares
$39.92
$3.40
Holding Value $7.79M 2,292,060 shares
Last Trade
Dec 18, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.4B 800,000 shares
$1,750.00
$3.40
Pfizer Inc 10% owner
Holding Value $0 0 shares
Last Trade
Dec 18, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$3.92B 2,238,090 shares
$1,750.00
$3.40
Short Carolyn Anderson 10% owner, See Remarks
Holding Value $21.1M 6,220,050 shares
Last Trade
Dec 15, 2020 Sale
No data
No data
$3.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up